动静脉畸形相关颅内动脉瘤的血管内治疗:一项系统性文献综述
该系统综述按PRISMA指南纳入8项研究、237例患者和314个动静脉畸形相关颅内动脉瘤,评估血管内治疗方法、影像学结局及围手术期并发症。动脉瘤弹簧圈栓塞完全闭塞率为56.3%(18/32),载瘤血管牺牲为99%(104/105);围手术期并发症率约12%。
要点
- 314个动脉瘤中,血流相关224个(71.3%)、瘤巢内80个(25.5%)、无关10个(3.2%)。
- 动脉瘤弹簧圈栓塞完全闭塞率56.3%(18/32),载瘤血管牺牲99%(104/105)。
- 13个动脉瘤行乙醇硬化治疗,单用乙醇闭塞8个(8/13;61%),其余需辅助栓塞。
核心结论
- 动静脉畸形相关颅内动脉瘤的血管内治疗选择有限,主要包括动脉瘤弹簧圈栓塞或使用弹簧圈或液体栓塞剂行载瘤血管牺牲。
- 栓塞策略取决于动静脉畸形血管构筑、破裂状态及辅助动静脉畸形治疗等因素。
研究设计与样本
- 按PRISMA指南进行的系统性文献综述,纳入8项研究、237例患者和314个动静脉畸形相关颅内动脉瘤。
主要发现
- 224个动脉瘤为血流相关(71.3%),80个为瘤巢内(25.5%),10个为无关(3.2%)。
- 动脉瘤弹簧圈栓塞完全闭塞率为56.3%(18/32),载瘤血管牺牲为99%(104/105)。
- 13个动脉瘤行乙醇硬化治疗,单用乙醇硬化治疗闭塞8个(8/13;61%),其余需辅助血管内栓塞以闭塞动脉及关联动脉瘤。
- 围手术期并发症率约12%,包括缺血症状、颅内出血和弹簧圈相关并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intracranial aneurysms are present in up to 18% of arteriovenous malformations (AVMs) and increase the risk of intracranial hemorrhage. No consensus exists on the optimal treatment strategy for AVM-associated aneurysms. The goal of this study was to systematically review endovascular treatment methods of AVM-associated intracranial aneurysms, radiographic outcomes, and periprocedural complications. METHODS: A systematic review was performed in accordance with PRISMA guidelines to identify studies that investigated the use of endovascular treatments for management of patients with AVM-associated aneurysms. Collected variables included aneurysm and AVM location, aneurysm size and characteristics, AVM and aneurysm treatment modality, periprocedural complications, and long-term clinical and radiographic outcomes. RESULTS: Eight studies with 237 patients and 314 AVM-associated intracranial aneurysms were included. Two-hundred and twenty-four aneurysms were flow-related (71.3%), 80 were intranidal (25.5%), and 10 were unrelated (3.2%). Complete occlusion was 56.3% (18/32) for aneurysmal coil embolization and 99% (104/105) for parent vessel sacrifice. Of the 13 aneurysms treated with ethanol sclerotherapy, 8 were successfully obliterated (8/13; 61%) using ethanol sclerotherapy alone and the rest required adjunct endovascular embolization for obliteration of the artery and associated aneurysm. The periprocedural complication rate was approximately 12% and consisted of ischemic symptoms, intracranial hemorrhage, and coiling complications. CONCLUSIONS: Endovascular management options of AVM-associated intracranial aneurysms are limited and mostly comprised primary aneurysmal coil embolization or parent vessel sacrifice using coils or liquid embolics. Embolization strategy depends on factors such as AVM angioarchitecture, rupture status, and adjunct AVM treatments.
引用
- El-Abtah ME, Petitt JC, Kashkoush A, et al. Endovascular Management of Arteriovenous Malformation-Associated Intracranial Aneurysms: A Systematic Literature Review. World Neurosurg. 2022. PMID: 35597540. doi:10.1016/j.wneu.2022.05.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。